New spin-out company to develop new technology for the global microscopy market
Biofusion plc (“Biofusion”), the university intellectual property (IP) commercialisation company, today announces the launch of a new portfolio company, Phase Focus Ltd (“Phase Focus”), and an initial investment of £200,000 to provide for further development and validation of its proprietary technology.
Phase Focus is developing an alternative approach to microscopy and imaging that does not rely on sophisticated lenses and has applications in optical, x-ray and electron microscopy, amongst others. Professor John Rodenburg, a founder of Phase Focus, has patent applications pending for a process that can generate high definition images of an object without the need for the high quality lenses that account for a significant element of the cost of high-performance microscopes.
Dr Ian Pykett, who has 19 years experience in management of technology companies, has been appointed as CEO to Phase Focus.
David Baynes, CEO of Biofusion said:
“Phase Focus is our fourth new company and takes the number of spin-out companies in our portfolio to twelve. We believe Professor Rodenburg’s breakthrough has the potential to create a new generation of ‘lensless’ microscopes, which will produce better images at a lower cost, in the electron and optical microscopy market, a market which is forecast to grow to $1.6 billion by 2009.”